Hideki Arima
Impact in
-
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis of heterocyclic compounds
- Multicomponent Synthesis of Heterocycles
Papers in ⓘ
-
- Chemical Reactions and Isotopes 2
- Co-authors
- K. Tomioka (2 shared papers)Toshiyasu Mase (2 shared papers)Toshimitsu Yamada (1 shared paper)Y. ISOMURA (3 shared papers)Tadao Kojima (2 shared papers)Toichi Takenaka (2 shared papers)Michio Terai (2 shared papers)Shigeo Fujita (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)European Journal of Medicinal Chemistry (1 paper)Journal of Clinical Oncology (1 paper)BMC Infectious Diseases (1 paper)Biomedicines (1 paper)
- Partner nations
- JapanUnited Kingdom
In The Last Decade
Hideki Arima
16 papers receiving 176 citations
Peers
Comparison fields: 5 of 60
- Organic Chemistry 96
- Molecular Medicine 13
- Pharmacology 19
- Pharmacology 20
- Endocrinology 6
Countries citing papers authored by Hideki Arima
This map shows the geographic impact of Hideki Arima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Arima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Arima more than expected).
Fields of papers citing papers by Hideki Arima
This network shows the impact of papers produced by Hideki Arima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Arima. The network helps show where Hideki Arima may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideki Arima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 78 | |
| 2 | 1986 | 51 | |
| 3 | 2019 | 17 | |
| 4 | 2022 | 11 | |
| 5 | 1988 | 10 | |
| 6 | 2005 | 6 | |
| 7 | 1988 | 4 | |
| 8 | 1979 | 4 | |
| 9 | [Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis]. | 1995 | 3 |
| 10 | 1985 | 3 | |
| 11 | 1983 | 3 | |
| 12 | 1999 | 2 | |
| 13 | 1983 | 2 | |
| 14 | 1985 | 2 | |
| 15 | 2010 | 1 | |
| 16 | Autoclave Application for Zinc Leach Residue Treatment by Akita Zinc Co., Ltd | 2004 | 1 |
| 17 | 1984 | 1 | |
| 18 | 2017 | 1 |
About Hideki Arima
Hideki Arima is a scholar working on Pharmacology, Pharmaceutical Science, Organic Chemistry, Molecular Medicine and Endocrinology, having authored 18 papers that have together received 200 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Synthesis and Biological Evaluation (3 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Chemical Reactions and Isotopes (2 papers), Cancer therapeutics and mechanisms (2 papers), Synthesis and biological activity (2 papers), Synthesis of heterocyclic compounds (2 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Organic Chemistry (96 citations), Molecular Medicine (13 citations), Pharmacology (19 citations), Pharmacology (20 citations) and Endocrinology (6 citations). Hideki Arima has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include K. Tomioka, Toshiyasu Mase, Toshimitsu Yamada, Y. ISOMURA, Tadao Kojima, Toichi Takenaka, Michio Terai, Shigeo Fujita, Osamu Inagaki and Minoru Okada. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Journal of Clinical Oncology, BMC Infectious Diseases and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.